Communications Medicine (May 2023)

Deep learning-based electrocardiographic screening for chronic kidney disease

  • Lauri Holmstrom,
  • Matthew Christensen,
  • Neal Yuan,
  • J. Weston Hughes,
  • John Theurer,
  • Melvin Jujjavarapu,
  • Pedram Fatehi,
  • Alan Kwan,
  • Roopinder K. Sandhu,
  • Joseph Ebinger,
  • Susan Cheng,
  • James Zou,
  • Sumeet S. Chugh,
  • David Ouyang

DOI
https://doi.org/10.1038/s43856-023-00278-w
Journal volume & issue
Vol. 3, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Undiagnosed chronic kidney disease (CKD) is a common and usually asymptomatic disorder that causes a high burden of morbidity and early mortality worldwide. We developed a deep learning model for CKD screening from routinely acquired ECGs. Methods We collected data from a primary cohort with 111,370 patients which had 247,655 ECGs between 2005 and 2019. Using this data, we developed, trained, validated, and tested a deep learning model to predict whether an ECG was taken within one year of the patient receiving a CKD diagnosis. The model was additionally validated using an external cohort from another healthcare system which had 312,145 patients with 896,620 ECGs between 2005 and 2018. Results Using 12-lead ECG waveforms, our deep learning algorithm achieves discrimination for CKD of any stage with an AUC of 0.767 (95% CI 0.760–0.773) in a held-out test set and an AUC of 0.709 (0.708–0.710) in the external cohort. Our 12-lead ECG-based model performance is consistent across the severity of CKD, with an AUC of 0.753 (0.735–0.770) for mild CKD, AUC of 0.759 (0.750–0.767) for moderate-severe CKD, and an AUC of 0.783 (0.773–0.793) for ESRD. In patients under 60 years old, our model achieves high performance in detecting any stage CKD with both 12-lead (AUC 0.843 [0.836–0.852]) and 1-lead ECG waveform (0.824 [0.815–0.832]). Conclusions Our deep learning algorithm is able to detect CKD using ECG waveforms, with stronger performance in younger patients and more severe CKD stages. This ECG algorithm has the potential to augment screening for CKD.